metaMe Health is committed to developing FDA approved prescription digital therapeutics for the treatment of gastrointestinal conditions.
Regulora™ for IBS
metaMe Health is currently developing Regulora™ for IBS to become the first FDA-cleared prescription-only digital therapeutic for the treatment of Irritable Bowel Syndrome (IBS). More than 30 million Americans are affected by IBS, and the abdominal pain, diarrhea, and/or constipation that comes with it. Regulora™ for IBS provides relief by digitizing a standardized Brain-Gut therapy approach that has been clinically proven to be effective in reducing IBS symptoms in more than 25 Randomized Control Trials.